Scott Aaronson, MD

Director of Clinical Research; Psychiatrist, The Retreat at Sheppard Pratt


  • Adult Psychiatry
  • Biological Psychiatry
  • Depression
  • Medication Management
  • Mood Disorders
  • Psychopharmacology
  • Transcranial Magnetic Stimulation (TMS)
  • Treatment-resistant Depression

Dr. Scott Aaronson is a thought leader in the areas of biological psychiatry, diagnosis, and the integration of somatic and psychological therapies. He is a clinical associate professor of psychiatry at the University of Maryland School of Medicine, distinguished fellow of the American Psychiatric Association, and is a fellow of the American College of Psychiatrists. Dr. Aaronson also serves on the board of the American Society of Clinical Psychopharmacology and the board of the Clinical TMS Society. He is the chairman of the mentorship committee for the Society of Biological Psychiatry. 

In addition to his work at The Retreat, Dr. Aaronson is the director of clinical research at Sheppard Pratt, where he is the principal investigator for multiple studies on the development of therapies for mood, anxiety, and psychotic disorders. He has particularly been involved with the development of new strategies to alleviate the symptoms in treatment resistant mood disorders, and has published numerous articles on his research including pivotal studies in the use of devices—Transcranial Magnetic Stimulation (TMS) and Vagus Nerve Stimulation (VNS) in the treatment of severe refractory mood disorders.